Teva’s Oxaliplatin Injection Gets FDA Approval, Launched
Teva has announced the FDA approval and launch of Oxaliplatin Injection. Teva’s 505(b)(2) New Drug Application provides for the use of Oxaliplatin Injection, 50mg/10ml and 100mg/20ml, for adjuvant
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.